Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myelomonocytic, Chronic × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

fludarabine phosphate 32 Cyclophosphamide 27 Whole-Body Irradiation 25 Mycophenolic Acid 24 Azacitidine 24 Tacrolimus 20 Peripheral Blood Stem Cell Transplantation 20 Busulfan 20 Cyclosporine 14 Methotrexate 12 Antilymphocyte Serum 12 Decitabine 11 Cytarabine 11 Melphalan 10 Filgrastim 8 fludarabine 7 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 thymoglobulin 6 Sirolimus 6 Rituximab 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 Clofarabine 6 venetoclax 5 Cyclosporins 5 Sorafenib 4 Injections 4 Flow Cytometry 4 pevonedistat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡